Latest S-1 registration statements

QuasarEdge Acquisition Corporation, a blank check company, filed an S-1 registration statement for an initial public offering of 10 million units at $10.00 each, aiming to raise $100 million for a business combination.

AIAI Holdings Corporation plans a direct listing on Nasdaq, integrating proprietary AI into newly acquired companies across diverse sectors, despite reporting a pro forma net loss of $159.7 million for 2025.

Transglobal Management Group, Inc. filed an S-1 registration statement to allow a selling stockholder to resell shares and facilitate future equity financing, while auditors express substantial doubt about the company's ability to continue as a going concern.

Cortigent, a pre-revenue neurostimulation company, is pursuing a $15 million IPO to advance its artificial vision and stroke recovery systems, despite ongoing operating losses and a 'going concern' warning.

Medline Inc. selling stockholders are offering 75 million Class A common shares, with the company receiving no proceeds from the sale.

iShares Staked Ethereum Trust ETF, sponsored by iShares Delaware Trust Sponsor LLC, files an amended registration statement for its new ETF aiming to track ether's price and staking rewards.

Rise Gold Corp. filed an S-1 registration statement for the resale of up to 63,097,323 common shares by existing stockholders, while continuing to pursue legal avenues for its Idaho-Maryland Mine Project.

Long Table Growth Corp., a Cayman Islands exempted blank check company, filed an S-1/A registration statement for an initial public offering of 20,000,000 units at $10.00 each, aiming to raise $200 million for a business combination.

SUMA Acquisition Corporation, a blank check company, filed an S-1/A registration statement for an initial public offering of 15 million units at $10.00 each, aiming to raise capital for a business combination in the North American technology sector.

AfterNext Acquisition I Corp., a Cayman Islands blank check company, filed an S-1/A for a $100 million IPO to acquire a fintech or technology-enabled financial services company in Asia-Pacific, excluding Mainland China, Hong Kong, or Macau.

Grayscale Avalanche Trust (AVAX) filed an S-1/A registration statement to list its shares on NASDAQ, detailing its financial performance, operational structure, and future plans for staking AVAX.

Collab Z Inc. is pursuing an initial public offering to raise $13.3 million, aiming to expand its community-based property management platform with AI features and reduce reliance on related party revenues.

MiniMed Group, a global leader in diabetes technology, filed an S-1/A for its initial public offering of 28 million shares, showcasing robust revenue growth and product innovation despite reporting significant net losses and operational challenges.

Modular Medical, a pre-revenue medical device company, is conducting a best-efforts offering of up to $12 million in common stock and warrants to fund operations and commercialize its Pivot insulin pump, despite significant operating losses and going concern uncertainty.

Nightfood Holdings, operating as TechForce Robotics, reports significant losses and a going concern warning despite strategic acquisitions in hospitality and robotics.

Farlong Holding Corporation filed an S-1/A for its initial public offering of 4,000,000 shares at an estimated $4.00 per share, while acknowledging significant accumulated deficits and recurring losses raising substantial doubt about its ability to continue as a going concern.

Inflection Point Acquisition Corp. VI filed an S-1/A for its initial public offering of 22 million units at $10.00 each, aiming to raise $220 million for a business combination in disruptive growth sectors.

APEX Tech Acquisition Inc. filed an S-1MEF to increase its public offering of ordinary shares and rights, reflecting a revised unit structure.

Amaze Holdings, Inc. filed an S-1/A to register up to 50 million shares for resale by a selling stockholder, potentially raising $25 million through an equity line of credit while facing significant dilution and ongoing losses.

Netcapital Inc. filed an S-1/A to register the resale of up to 1.88 million shares, while also disclosing a Nasdaq non-compliance notice due to its stock price falling below $1.00.

GalaxyEdge Acquisition Corporation, a blank check company, is launching a $100 million initial public offering, but faces significant risks including management conflicts and regulatory uncertainties tied to potential China-based acquisitions.

Blue Water Acquisition Corp. IV, a SPAC targeting biotechnology, healthcare, and technology sectors, filed an S-1/A for its initial public offering of 12.5 million units at $10.00 each.

MiniMed Group, Inc., a global medical technology company specializing in diabetes management, filed an amended S-1 registration statement detailing its initial public offering of 28 million shares and its spin-off from Medtronic, aiming to accelerate growth as an independent entity.

Mobix Labs, an early-stage semiconductor firm, registered 24.1 million shares for resale while reporting significant losses and expressing substantial doubt about its ability to continue as a going concern.

ClearThink 1 Acquisition Corp. filed an S-1MEF to increase its public offering of Class A ordinary shares by 1.5 million, with each unit now including a right to receive one-fifth of an ordinary share.

Hillhouse Frontier Holdings Inc. filed an S-1/A for its initial public offering of 3.75 million Class A common shares, seeking to raise capital for expansion despite a significant drop in net income and gross profit in 2025.

Brookline Capital Acquisition Corp II filed an S-1/A for a $100 million initial public offering of units, aiming to acquire businesses in the healthcare and defense technology sectors.

Breeze Acquisition Corp. II, a blank check company, is launching a $125 million initial public offering to seek a business combination in high-growth technology and healthcare sectors.

Bimergen Energy Corporation filed an S-1MEF to register an additional $3.6 million in securities for its public offering, while its auditor noted a going concern risk.

Propanc Biopharma, a development-stage cancer treatment company, reported significant losses and a going concern warning, despite recent patent filings and capital raises.